StockNews.com Begins Coverage on OpGen (NASDAQ:OPGN)
Research analysts at StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the medical research company’s stock. OpGen Stock Performance OpGen stock opened at $0.39 on Wednesday. OpGen has a fifty-two week low of […]